← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Rosalind Franklin Univ Of Medicine & Sci
North Chicago, IL
$153,317,389
Total funding
166
Grants
Funding over time
peak $10.6M · FY2006–25$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$153,317,389 · 166
By mechanism
R01$118,839,526 · 82
R21$13,729,552 · 35
RF1$3,667,584 · 2
R56$2,925,726 · 7
R35$2,198,967 · 1
R37$2,047,914 · 1
Investigators at Rosalind Franklin Univ Of Medicine & Sci
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Largest grants
Novel Drug Discovery for AD Targeting Ryanodine Calcium Channels$1,950,000
RF1 · FY2016 · AG
Intracellular organelle deficits driving Alzheimer's disease$1,717,584
RF1 · FY2020 · AG
A longitudinal and experience sampling investigation of rejection sensitivity and its role in sexual minority adolescents' mental health$800,360
R01 · FY2023 · MH
A longitudinal and experience sampling investigation of rejection sensitivity and its role in sexual minority adolescents' mental health$730,806
R01 · FY2025 · MH
A longitudinal and experience sampling investigation of rejection sensitivity and its role in sexual minority adolescents' mental health$726,126
R01 · FY2024 · MH
Positive allosteric modulator PNU-120596 to treat HIV-associated neurocognitive disorders$678,398
R01 · FY2024 · DA
Positive allosteric modulator PNU-120596 to treat HIV-associated neurocognitive disorders$678,398
R01 · FY2025 · DA
Neural Substrate of Cognitive and Emotional Deficits in Psychopathy$673,703
R01 · FY2011 · MH
Neural Substrate of Cognitive and Emotional Deficits in Psychopathy$636,396
R01 · FY2012 · MH
Neural Substrate of Cognitive and Emotional Deficits in Psychopathy$617,901
R01 · FY2013 · MH
Reading Frame Correction for the Treatment of Batten Disease$609,223
R01 · FY2021 · NS
LTQ Orbitrap Velos Mass Spectrometer with ETD$600,000
S10 · FY2012 · OD
Reprogramming Cell Fate for Repair$582,005
R01 · FY2017 · NS
Reading Frame Correction for the Treatment of Batten Disease$581,344
R01 · FY2023 · NS
HIV Infection and Latency In Astrocytes$575,693
R01 · FY2020 · DA
HIV Infection and Latency In Astrocytes$575,693
R01 · FY2019 · DA
Neural Substrate of Cognitive and Emotional Deficits in Psychopathy$574,327
R01 · FY2014 · MH
Reading Frame Correction for the Treatment of Batten Disease$572,075
R01 · FY2020 · NS
Reprogramming Cell Fate for Repair$565,096
R01 · FY2018 · NS
Reprogramming Cell Fate for Repair$560,843
R01 · FY2019 · NS